(MENAFN- GlobeNewsWire - Nasdaq) Increasing Number of People Getting Affected with Diabetes-Related Gangrene Worldwide Pushing Demand for Soft Tissue Repair Products
Rockville, MD, Oct. 24, 2024 (GLOBE NEWSWIRE) -- According to a new industry report released by Fact.MR, the global soft tissue repair market size is expected to reach a size of US$ 7.39 billion in 2024 and further expand at 5.6% CAGR , to reach a value of US$ 12.78 billion by the end of 2034.
Because of the increasing aging population, demand for orthopedic procedures is increasing at a significant pace, offering lucrative prospects for soft tissue repair solution providers. Chronic conditions like diabetes-related gangrene, osteoarthritis, and peripheral vascular disease are boosting the demand for orthopedic procedures, including amputations. Consequently, there is a surge in overall sales within the soft tissue repair market.
Increased investment in soft tissue repair research and development fuels market expansion, fostering the introduction of novel products and technological advancements. This market is experiencing substantial growth, offering substantial opportunities for the healthcare sector.
For More Insights into the Market, Download a Sample of this Report:
Key Takeaways from Market Study
The market is forecasted to expand at a CAGR of 6% from 2024 to 2034. Sales of soft tissue repair products in the United States are placed to reach US$ 3.05 billion in 2024. Brazil is set to occupy 6% market share in East Asia in 2024. The market in Canada is estimated to reach a value of US$ 511 million in 2024. The North American market is forecasted to expand at a CAGR of 9% from 2024 to 2034.
“Development of products for soft tissue repair has resulted from the growing preference for minimally invasive procedures. Increasing prevalence of sports-related injuries is an additional factor driving market growth,” says a Fact.MR analyst.
Leading Players Driving Innovation in the Soft Tissue Repair Market:
Smith & Nephew Plc.; Medtronic Plc.; Arthrex, Inc.; Medprin Biotech; Zimmer Biomet; Stryker Corporation; Baxter International, Inc.; Stryker; Medtronic; Acera Surgical Inc.; Arthrex Inc.; Integra LifeSciences; Acelity L.P. Inc.; Aroa Biosurgery Limited; Becton, Dickinson and Company; Conmed.
Rising Awareness of Injury Prevention and Rehabilitation in United Kingdom
The United Kingdom is a key player in the soft tissue repair market due to its extensive healthcare system and active population. Due to the increasing awareness of the importance of sports injury prevention and rehabilitation, the country is seeing notable advancements in this field. Prominent healthcare providers and medical equipment manufacturers also benefit the UK market. These companies continually bring innovative soft tissue repair products and methods to the market, which helps it grow. Due to its commitment to healthcare research and development, which fosters the development of cutting-edge soft tissue repair technologies, the United Kingdom is a major player in the global market.
Soft Tissue Repair Industry News:
Theradaptive, a biopharmaceutical company leading the way in regenerative treatments, and 3D Systems, a prominent developer of additive manufacturing technology, signed a partnership designating 3D Systems as Theradaptive's 3D printing partner. The main goal of the firms was to offer a new method of promoting bone and tissue growth by using medical devices from 3D Systems and unique Theradaptive material binding variants.
In December 2022, Stryker debuted the Citrefix suture anchor system, designed specifically for foot and ankle surgery. The invention features a disposable suture anchor system and a resorbable biomimetic anchor body, in contrast to traditional anchor systems.
In May 2022, Paragon 28 Inc. released the Grappler Suture Anchor System, which significantly eased the challenges related to ligament restoration and soft tissue tensioning in acute foot and ankle surgeries.
Get Customization on this Report for Specific Research Solutions:
More Valuable Insights on Offer
in its new offering, presents an unbiased analysis of the soft tissue repair market for 2019 to 2023 and forecast statistics for 2024 to 2034.
The study divulges the soft tissue repair market based on product type (synthetic, allograft, xenograft, alloplast), application (breast reconstruction, hernia, dermatology, orthopedics, dental problems, vaginal sling), and end user (hospitals, ambulatory surgical centers, clinics) across seven major regions of the world (North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia & Pacific, and MEA).
Checkout More Related Studies Published by Fact.MR Research:
Soft Tissue Allografts Market Analysis by Cartilage Allografts, Tendon Allografts, Meniscus Allografts, Dental Allografts, and Others for Hospitals, Aesthetic Centers, and Others from 2023 to 2033
Soft Tissue Anchor Market Study by Absorbable and Non-Absorbable Metallic Suture Anchors, Bio-absorbable Suture Anchors, PEEK Sutures, All Suture, and Bio-composite Suture Anchors from 2024 to 2034
Tissue Processing System Market Study by Small Volume Tissue Processors, Medium Volume Tissue Processors, Rapid High Volume Tissue Processors from 2024 to 2034
Tissue Glue and Bio-adhesive Sealant Market Study by Protein-based, Collagen-based, Thrombin-based, Fibrin, and Gelatin-based Sealants from 2024 to 2034
Hemostasis and Tissue Sealing Agents Market Analysis By Product (Topical Hemostats, Adhesive & Tissue Sealants), By End User (Hospitals, Ambulatory Surgery Centers, Home Care Settings, Others), & By Region - 2024 to 2034.
About Us:
Fact.MR is a distinguished market research company renowned for its comprehensive market reports and invaluable business insights. As a prominent player in business intelligence, we deliver deep analysis, uncovering market trends, growth paths, and competitive landscapes. Renowned for its commitment to accuracy and reliability, we empower businesses with crucial data and strategic recommendations, facilitating informed decision-making and enhancing market positioning. With its unwavering dedication to providing reliable market intelligence, FACT.MR continues to assist companies in navigating dynamic market challenges with confidence and achieving long-term success. With a global presence and a team of experienced analysts, FACT.MR ensures its clients receive actionable insights to capitalize on emerging opportunities and stay ahead in the competitive landscape.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Sales Team : ...
Follow Us: LinkedIn | Twitter | Blog
MENAFN24102024004107003653ID1108815374
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.